About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

The Dow Jones closed lower by around 270 points to 42,140.43 on Tuesday. The S&P 500 surged 0.72% to 5,886.55, while the Nasdaq Composite jumped 1.61% at 19,010.08 during Tuesday's session. Investors are awaiting earnings results from Sony Group Corporation SONY, Cisco Systems, Inc. CSCO and MakeMyTrip Limited MMYT today. The CNN Money Fear and Greed index showed further improvement in the overall market sentiment, while the index remained in the "Greed" zone on Tuesday. U.S. stocks settled mixed on Tuesday ...

Still, considering the ongoing uncertainty, investors might want to buy stocks that have limited exposure to tariffs and global trade tensions. Here are three great options to consider. The Nasdaq Composite (^IXIC 1.61%) technology index was down by as much as 24% from its all-time high in April, placing it in a bear market. The sell-off was triggered by President Donald Trump's "Liberation Day" tariffs, which sparked fears of a sharp economic slowdown. But several countries are negotiating new trade deals ...

The three major benchmarks soared on Monday as the U.S. announced an initial import tariff agreement with China. This was a game-changing moment for investors as concerns about President Donald Trump's tariff plan had weighed on sentiment for weeks. Investors were particularly worried about an escalating trade war with China that could wreak havoc on the economy. But that worst-case scenario seems to be drifting away. This week, the U.S. agreed to set tariffs at 30% on China, a level light-years away from t ...

Company Overview - eToro has priced its IPO at $52 per share, raising nearly $310 million and valuing the company at approximately $4.2 billion [1] - Founded in 2007 by brothers Yoni and Ronen Assia along with David Ring, eToro competes with platforms like Robinhood and generates revenue through trading fees and non-trading activities [5] Financial Performance - eToro's net income surged almost thirteenfold to $192.4 million in the last year, up from $15.3 million the previous year [6] - Revenue from cryptoassets more than tripled to over $12 million in 2024, with one-quarter of its net trading contribution coming from crypto, an increase from 10% the prior year [6] IPO Context - The IPO market is showing signs of recovery, with eToro's Nasdaq debut under the ticker symbol ETOR being a potential indicator of market readiness for risk [4] - eToro previously attempted to go public in 2022 through a SPAC merger, which was scrapped due to a downturn in equity markets [7] Investor Interest - BlackRock has expressed interest in purchasing $100 million in shares at the IPO price, with the company planning to sell 5 million shares in the offering, alongside existing investors selling another 5 million [8]

Core Viewpoint - The content emphasizes the importance of conducting personal due diligence and consulting competent advisors before making any financial decisions, particularly in the context of investments and trading activities [1]. Group 1 - The website provides general news, personal analysis, and third-party content intended for educational and research purposes [1]. - It explicitly states that the information does not constitute any recommendation or advice for investment actions [1]. - Users are advised to perform their own research and consider their financial situation before making decisions [1]. Group 2 - The website includes information about complex financial instruments such as cryptocurrencies and contracts for difference (CFDs), which carry a high risk of losing money [1]. - It encourages users to understand how these instruments work and the associated risks before investing [1].

Invesco is an independent investment management firm dedicated to delivering an investment experience that helps people get more out of life.Be the first to know! Sign up for Invesco US Blog and get expert investment views as they post.Disclosure for all Invesco US articles: Before investing, carefully read the prospectus and/or summary prospectus and carefully consider the investment objectives, risks, charges and expenses. The information provided is for educational purposes only and does not constitute a ...

Core Viewpoint - The Stock Exchange of Thailand (SET) and Nasdaq have announced an expanded strategic technology partnership aimed at modernizing Thailand's capital markets, focusing on enhancing market resilience, integrity, and aligning with global standards through the use of Nasdaq's AI capabilities [1][2]. Group 1: Partnership Objectives - The collaboration will promote the adoption of Nasdaq's risk and surveillance platforms within SET's member community to drive consistent infrastructure across the market ecosystem [2]. - The initiative aims to enhance systemwide efficiency, transparency, and risk management, benefiting from common market infrastructure and Nasdaq's ongoing investments in modernization [2][3]. Group 2: Market Impact - The partnership is expected to strengthen liquidity, transparency, and integrity in Thailand's capital markets, fostering trust and investor confidence [3]. - By adopting advanced risk and surveillance solutions, SET aims to improve its ability to detect market abuse and monitor trading activities, reinforcing Thailand's leadership in ASEAN's capital markets [3][4]. Group 3: Nasdaq's Global Reach - Nasdaq's technology is utilized by 97% of globally systematically important banks, half of the world's top 25 stock exchanges, and over 3,800 clients in the financial services industry [3]. - The partnership reflects Nasdaq's commitment to advancing industry-wide modernization through deep strategic relationships and mission-critical solutions [4]. Group 4: Future Vision - Together, SET and Nasdaq are laying the foundation for a robust, future-ready capital market ecosystem, enhancing Thailand's position as a regional innovation leader and financial hub [5].

Core Viewpoint - Hepion Pharmaceuticals has transitioned from developing treatments for chronic liver diseases to focusing on diagnostic tests, while facing delisting from Nasdaq due to non-compliance with listing standards [1][2]. Company Overview - Hepion Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that was previously developing treatments for non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) [1]. - The company's primary asset, Rencofilstat, is a potent inhibitor of cyclophilins, which has shown efficacy in reducing liver fibrosis and HCC tumor burden in experimental models [3]. Recent Developments - On May 9, 2025, the company received a notice from Nasdaq indicating that its shares would be delisted due to failure to maintain a minimum bid price of $1.00 per share and being classified as a public shell [1]. - Following the suspension of trading on Nasdaq, the company's shares are expected to be quoted on the OTC Markets Group under the existing symbol "HEPA" [2]. - Hepion announced a license agreement with New Day Diagnostics LLC on May 9, 2025, to in-license diagnostic tests for celiac disease, respiratory multiplex (Covid/Influenza A/B and RSV), H. pylori, and HCC, with some tests already having CE marks for sale in Europe [5]. Clinical Trials - In April 2024, Hepion decided to wind down its ASCEND-NASH clinical trial, which was a Phase 2b study aimed at evaluating the safety and efficacy of Rencofilstat over 12 months, with a target enrollment of 336 subjects [4]. - Enrollment in the trial was paused in April 2023 after 151 subjects were randomized, and approximately 80 subjects have completed their Day 365 visits [4].

Core Viewpoint - American Bitcoin Corp. has entered into a definitive merger agreement with Gryphon Digital Mining, Inc. to become a publicly traded entity focused on Bitcoin accumulation at scale [1] Company Overview - American Bitcoin is a majority-owned subsidiary of Hut 8, dedicated to industrial-scale Bitcoin mining and strategic Bitcoin reserve development [4] - The company aims to create a low-cost Bitcoin accumulation platform, leveraging Hut 8's mining operations and Eric Trump's expertise in capital markets [4] Transaction Details - The merger will be a stock-for-stock transaction, with the combined company expected to trade on Nasdaq under the ticker symbol "ABTC" [1][7] - The anticipated closing timeline for the transaction is targeted for Q3 2025 [7] - Post-transaction, existing stockholders of American Bitcoin are expected to own approximately 98% of the combined company [7] Management and Governance - The combined company will be led by the management and board of directors of American Bitcoin, including key figures such as Eric Trump and Asher Genoot [1][7]